Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Sanofi (SNY) Seeks Separation of Skin Sustaining Segment
-
Q3 Preview: Merck (MRK) Trading Strong Into Earnings, Looks to Nearly Double-Up Revs Y/Y (PFE, GSK, SNY)
-
Deutsche Bank Maintains a 'Hold' on Genzyme (GENZ); Genetics Sale-More Upside if Diagnostics Sold
-
Deutsche Bank Starts Genzyme (GENZ) at Hold, Sees Sanofi Deal Getting Done
-
Sanofi-Aventis (SNY) Cuts Outlook Amid Generic Lovenox Approval; Analysts Mixed
-
Notable Analyst Rating Changes 02/26: RST, AZN/GSK, CHA/CHU, OSIS, LAMR Upgraded; PALM, DPS, ATHN, FLR, MOT Downgraded
-
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Deutsche Bank Initiates Coverage on Sanofi-Aventis (SNY) with a Buy
-
Notable Analyst Rating Changes 10/14: CSC, GSK, SNY, ABX, CNO, HOG, TEL Upgrade; VLO, JBLU, AGCO Downgrade
-
Notable Analyst Rating Changes for 7/30: GE, TEL, YUM, GT, ELY Upgraded; MCD, DOW, AKAM, DRIV, SNY, SPF Downgraded
-
Notable Analyst Rating Changes 6/29: DFS, LYG, TRW, BCS, JCP Upgraded; AA, SNY, BIIB, WW Downgraded
-
Notable Analyst Rating Changes 6/10: YHOO, X, ZEUS, DB Upgraded; SINA, CRDN, FSLR, PLL Downgraded
-
Unusual 11 Mid-Day Movers 5/28: FREE, ANPI, OCLS, EXEL Higher; JMBA, NZ, REV, PNSN Lower
-
Morning Movers 5/28: FREE, EXEL, ANPI, GBE, PARD Higher; SPRD, NZ, PHHM, DSW, REV Lower
-
Notable Analyst Rating Changes 1/26: LEN, GRMN, LUV, PETM, LEAP Upgraded; BHP, BAC, USB, AFL, ENR Downgraded
-
Deutsche Bank Maintains a 'Hold' Rating on Sanofi-Aventis (SNY)
